Citation: V. Wsol et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY STUDY OF STEREOSPECIFIC MICROSOMAL-ENZYMES CATALYZING THE REDUCTION OF A POTENTIAL CYTOSTATIC DRUG, ORACIN - INTERSPECIES COMPARISON, Journal of chromatography, 797(1-2), 1998, pp. 197-201
Citation: F. Trejtnar et al., PHARMACOKINETICS OF A NEW ANTIFLOGISTIC FLOBUFEN AND ITS ENANTIOMERS IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 25-25
Citation: B. Szotakova et al., REDUCTION BIOTRANSFORMATION OF THE POTENTIAL CYTOSTATIC DRUG ORACIN AT CHIRAL LEVEL IN RATS IN-VITRO AND IN-VIVO, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 146-146
Citation: V. Wsol et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE SEPARATION AND CHARACTERIZATION OF METABOLITES OF THE POTENTIAL CYTOSTATIC DRUG ORACINE, Journal of chromatography B. Biomedical applications, 681(1), 1996, pp. 169-175